Prognostic value of mediastinal lymph node enlargement in chronic interstitial lung disease. 2021

Stefano Grecuccio, and Nicola Sverzellati, and Elisabetta Uslenghi, and Antonella Caminati, and Giueseppe Pedrazzi, and Maurizio Zompatori
Department of Radiology, University of Parma, Parma, Italy.

OBJECTIVE Mediastinal lymph node (MLN) enlargement detected on chest computed tomography (CT) is frequent in patients with interstitial lung disease (ILD) and is shown in approximately 70% of cases of idiopathic pulmonary fibrosis (IPF). We hypothesized that enlarged MLNs might be a predictor of poor prognosis, associated with lower survival and stronger disease severity. METHODS This study included patients with idiopathic pulmonary fibrosis (IPF) or nonspecific interstitial pneumonia (NSIP) from January 2009 to December 2018. Baseline chest CT scan and one-year follow-up scan of the patients were reviewed for the extent of lung fibrosis and MLNs. Two radiologists independently assessed MLN diameter and location. Patients with drug toxicity-related ILD, sarcoidosis, chronic hypersensitivity pneumonitis and other rare idiopathic interstitial pneumonias were excluded. The primary endpoint was survival. Secondary endpoints included number of hospitalizations for respiratory causes, lung function evaluated by forced vital capacity (FVC) and diffusing capacity for carbon monoxide (DLCO), and lung fibrosis score determined by CT scan. RESULTS We retrospectively reviewed the medical registries of 110 patients with chronic pulmonary fibrosis (mean age 71 years, 60.4% male). Nine participants were excluded because the CT scans were of poor diagnostic quality for the evaluation of the mediastinum or unavailable for review. The analysis of 101 patients showed that enlarged MLNs (short axis diameter ≥10 mm) were present in 50.5% (n=51) and strongly predicted survival (HR= 2.11, 95% CI 1.12-3.96, p = 0.020). Patients with MLN enlargement experienced greater number of hospitalizations for respiratory causes (mean 2.5 vs. 1.8, p = 0.010) and had significantly worse lung function parameters (FVC, 71% vs. 81%, p = 0.018 and DLCO, 40% vs. 50%, p = 0.001) and a higher lung fibrosis score (50% vs. 39%, p = 0.001). CONCLUSIONS In patients with IPF and NSIP, enlarged MLNs predict survival, are associated with increased number of hospitalizations, and show signs of poorer lung function and more severe fibrosis.

UI MeSH Term Description Entries
D008168 Lung Either of the pair of organs occupying the cavity of the thorax that effect the aeration of the blood. Lungs
D008198 Lymph Nodes They are oval or bean shaped bodies (1 - 30 mm in diameter) located along the lymphatic system. Lymph Node,Node, Lymph,Nodes, Lymph
D008297 Male Males
D011379 Prognosis A prediction of the probable outcome of a disease based on a individual's condition and the usual course of the disease as seen in similar situations. Prognostic Factor,Prognostic Factors,Factor, Prognostic,Factors, Prognostic,Prognoses
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D012189 Retrospective Studies Studies used to test etiologic hypotheses in which inferences about an exposure to putative causal factors are derived from data relating to characteristics of persons under study or to events or experiences in their past. The essential feature is that some of the persons under study have the disease or outcome of interest and their characteristics are compared with those of unaffected persons. Retrospective Study,Studies, Retrospective,Study, Retrospective
D017563 Lung Diseases, Interstitial A diverse group of lung diseases that affect the lung parenchyma. They are characterized by an initial inflammation of PULMONARY ALVEOLI that extends to the interstitium and beyond leading to diffuse PULMONARY FIBROSIS. Interstitial lung diseases are classified by their etiology (known or unknown causes), and radiological-pathological features. Diffuse Parenchymal Lung Disease,Diffuse Parenchymal Lung Diseases,Interstitial Lung Disease,Interstitial Lung Diseases,Pneumonia, Interstitial,Pneumonitis, Interstitial,Interstitial Pneumonia,Interstitial Pneumonias,Interstitial Pneumonitides,Interstitial Pneumonitis,Lung Disease, Interstitial,Pneumonias, Interstitial,Pneumonitides, Interstitial
D054990 Idiopathic Pulmonary Fibrosis A common interstitial lung disease of unknown etiology, usually occurring between 50-70 years of age. Clinically, it is characterized by an insidious onset of breathlessness with exertion and a nonproductive cough, leading to progressive DYSPNEA. Pathological features show scant interstitial inflammation, patchy collagen fibrosis, prominent fibroblast proliferation foci, and microscopic honeycomb change. Cryptogenic Fibrosing Alveolitis,Familial Idiopathic Pulmonary Fibrosis,Fibrocystic Pulmonary Dysplasia,Fibrosing Alveolitis, Cryptogenic,Idiopathic Fibrosing Alveolitis, Chronic Form,Idiopathic Pulmonary Fibrosis, Familial,Interstitial Pneumonitis, Usual,Pulmonary Fibrosis, Idiopathic,Usual Interstitial Pneumonia,Cryptogenic Fibrosing Alveolitides,Dysplasia, Fibrocystic Pulmonary,Fibrocystic Pulmonary Dysplasias,Fibrosing Alveolitides, Cryptogenic,Idiopathic Pulmonary Fibroses,Interstitial Pneumonia, Usual,Pneumonitides, Usual Interstitial,Pneumonitis, Usual Interstitial,Pulmonary Dysplasia, Fibrocystic,Pulmonary Fibroses, Idiopathic,Usual Interstitial Pneumonias,Usual Interstitial Pneumonitides,Usual Interstitial Pneumonitis

Related Publications

Stefano Grecuccio, and Nicola Sverzellati, and Elisabetta Uslenghi, and Antonella Caminati, and Giueseppe Pedrazzi, and Maurizio Zompatori
April 2006, AJR. American journal of roentgenology,
Stefano Grecuccio, and Nicola Sverzellati, and Elisabetta Uslenghi, and Antonella Caminati, and Giueseppe Pedrazzi, and Maurizio Zompatori
February 1990, AJR. American journal of roentgenology,
Stefano Grecuccio, and Nicola Sverzellati, and Elisabetta Uslenghi, and Antonella Caminati, and Giueseppe Pedrazzi, and Maurizio Zompatori
July 1980, Seminars in roentgenology,
Stefano Grecuccio, and Nicola Sverzellati, and Elisabetta Uslenghi, and Antonella Caminati, and Giueseppe Pedrazzi, and Maurizio Zompatori
January 1983, Schweizerische medizinische Wochenschrift,
Stefano Grecuccio, and Nicola Sverzellati, and Elisabetta Uslenghi, and Antonella Caminati, and Giueseppe Pedrazzi, and Maurizio Zompatori
August 2011, Zhonghua jie he he hu xi za zhi = Zhonghua jiehe he huxi zazhi = Chinese journal of tuberculosis and respiratory diseases,
Stefano Grecuccio, and Nicola Sverzellati, and Elisabetta Uslenghi, and Antonella Caminati, and Giueseppe Pedrazzi, and Maurizio Zompatori
May 2023, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease,
Stefano Grecuccio, and Nicola Sverzellati, and Elisabetta Uslenghi, and Antonella Caminati, and Giueseppe Pedrazzi, and Maurizio Zompatori
July 1995, Clinical radiology,
Stefano Grecuccio, and Nicola Sverzellati, and Elisabetta Uslenghi, and Antonella Caminati, and Giueseppe Pedrazzi, and Maurizio Zompatori
January 2003, Journal of computer assisted tomography,
Stefano Grecuccio, and Nicola Sverzellati, and Elisabetta Uslenghi, and Antonella Caminati, and Giueseppe Pedrazzi, and Maurizio Zompatori
December 1982, Journal of nuclear medicine : official publication, Society of Nuclear Medicine,
Stefano Grecuccio, and Nicola Sverzellati, and Elisabetta Uslenghi, and Antonella Caminati, and Giueseppe Pedrazzi, and Maurizio Zompatori
January 2015, Lung India : official organ of Indian Chest Society,
Copied contents to your clipboard!